The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Overproduction of large VLDL particles is driven by increased liver fat content in man
Open accessAbstract
Aims/hypothesis We determined whether hepatic fat content and plasma adiponectin concentration regulate VLDL(1) production.Methods A multicompartment model was used to simultaneously determine the kinetic parameters of triglycerides (TGs) and apolipoprotein B (ApoB) in VLDL(1) and VLDL(2) after a bolus of [(2)H(3)]leucine and [(2)H(5)]glycerol in ten men with type 2 diabetes and in 18 non-diabetic men. Liver fat content was determined by proton spectroscopy and intra-abdominal fat content by MRI.Results Univariate regression analysis showed that liver fat content, intra-abdominal fat volume, plasma glucose, insulin and HOMA-IR (homeostasis model assessment of insulin resistance) correlated with VLDL(1) TG and ApoB production. However, only liver fat and plasma glucose were significant in multiple regression models, emphasising the critical role of substrate fluxes and lipid availability in the liver as the driving force for overproduction of VLDL(1) in subjects with type 2 diabetes. Despite negative correlations with fasting TG levels, liver fat content, and VLDL(1) TG and ApoB pool sizes, adiponectin was not linked to VLDL(1) TG or ApoB production and thus was not a predictor of VLDL(1) production. However, adiponectin correlated negatively with the removal rates of VLDL(1) TG and ApoB.Conclusions/interpretation We propose that the metabolic effect of insulin resistance, partly mediated by depressed plasma adiponectin levels, increases fatty acid flux from adipose tissue to the liver and induces the accumulation of fat in the liver. Elevated plasma glucose can further increase hepatic fat content through multiple pathways, resulting in overproduction of VLDL(1) particles and leading to the characteristic dyslipidaemia associated with type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“and suggest the commonly observed relationship between increased VAT and metabolic disease (1-4) is because of the correlation between VAT and IHTG (8)(9)(10).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [3]
In the citing paper
“data from metabolic studies conducted on human subjects (3,4) indicate that an increase in VAT is associated with impaired glucose tolerance, insulin resistance, and increased very-low-density lipoproteintriglyceride (VLDL-TG) secretion.”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Lewis, G. F., Carpentier, A. C., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,370
Research works printed but not linked: 2
- World Health Organization (1999) Report of a WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Department of Noncommunicable Disease Surveillance. World Health Organization, Geneva
- Lindgren F, Jensen L (1972) The isolation and quantitative analysis of serum lipoproteins. In: Nelson GJ (ed.) Blood lipids and lipoproteins: quantification, composition and metabolism. Wiley, Livermore, CA, pp 182–217
Cited by
Sorted by citations
Items 601–689 of 689
Stanhope, K. L. (2015) · Wiley eBooks · doi:10.1002/9781119121725.ch5 · Cited by 1
Lehtonen, H.-M. (2010) · UTUPub (University of Turku) · Cited by 1
Hepatic steatosis in familial combined hyperlipidemia
Brouwers, M. C. G. J. (2008) · doi:10.26481/dis.20080307mb
The influence of walking on risk factors associated with metabolic syndrome
Scott, A. (2008) · Create (Canterbury Christ Church University)
Lipoproteins and Hyperlipoproteinemia: Links to Gout
Hsu, T. C. (2012) · Otago University Research Archive (University of Otago)
Cugat, K. U. (2007) · TDX (Tesis Doctorals en Xarxa)
Estudio genético y funcional de NR5A2, un factor de transcripción ligado a obesidad y diabetes
Bolado‐Carrancio, A. (2013) · UCrea (University of Cantabria)
Studies of Atherogenic Lipoproteins Using Mass Spectrometry-Based Lipidomics
Ståhlman, M. (2010) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Arsenic-induced developmental changes in the liver and adult cardiovascular disease.
Ngalame, N. N. O. (2011) · doi:10.18297/etd/1055
Gastrointestinal Physiology in Obesity
Miras, A. D., & le Roux, C. W. (2012) · doi:10.1002/9781119962083.ch3
Sterol-binding proteins in late endosomes : Regulation of endosome motility and lipid metabolism
Uronen, R. (2011) · Työväentutkimus Vuosikirja
Modulation of VLDL triglyceride metabolism
Bijland, S. (2010) · Leiden Repository (Leiden University)
Juurinen, L. (2014) · Työväentutkimus Vuosikirja
Association Between Fatty Liver and Cardiovascular Disease: Mechanism and Clinical Implications
Nseir, W., & Assy, N. (2011) · InTech eBooks · doi:10.5772/21294 · Cited by 1
Magalhães, A. J. B., Camargo, R. C. T., Castoldi, R. C., Ozaki, G. A. T., Koike, T. E., Garcia, T. A., Turato, V. G. G., da Silva, E. A. L., & Filho, J. C. S. C. (2015) · DOAJ (DOAJ: Directory of Open Access Journals)
LIVER FAT IN THE METABOLIC SYNDROME AND TYPE 2 DIABETES
Kotronen, A. (2008) · Työväentutkimus Vuosikirja
Adipose tissue inflammation, hepatic fat accumulation and insulin resistance
Kolak, M. (2008) · Figshare
Asubonteng, J. O. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Vascular risk factors and adipocyte dysfunction in metabolic syndrome
Hajer, G. R. (2008) · Utrecht University Repository (Utrecht University)
Novel factors affecting clearance of triacylglycerol-rich lipoproteins from blood
Nilsson, S. K. (2010)
STUDIES ON THE REGULATORY ROLES OF CHOLESTEROL AND BILE ACIDS
Murphy, C. (2007) · Figshare
MOLECULAR GENETICS OF PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING 3 AND CHRONIC LIVER DISEASE
Pirazzi, C. (2014) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Bebidas azucaradas, más que un simple refresco Soft drinks, more than just a simple drink
Silva, O. P., & Durán, A. (2014)
Taylor, R. (2013)
Endothelial Dysfunction and Dyslipidemia in Type 2 Diabetes: Pathogenesis, Significance and Therapy
Hamilton, S. J., & Watts, G. F. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_13
Protein kinase STK25 is a regulator of hepatic lipid partitioning and whole body metabolism
Amrutkar, M. (2016) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Ng, T. (2007) · UWA Profiles and Research Repository (UWA)
Quantitative Proteomic Investigation of Disease Models of Type 2 Diabetes
Athanason, M. G. (2016) · Digital Commons - University of South Florida (University of South Florida)
Tiwari, S. (2013) · Journal of International Crisis and Risk Communication Research
Mechanisms of Diet-induced Dyslipidemia and Insulin Resistance: Role of Chronic LXR Activation
Miller, A. (2008) · TSpace (University of Toronto)
Murugesan, V. (2017) · Lund University Publications (Lund University)
Effects of LXRα phosphorylation on the regulation of lipid metabolism and hepatic fibrosis
Bécares, N. (2017) · UCL Discovery (University College London)
Fiza, B., Sinha, M., Jain, L., & Kasliwal, R. (2017) · Journal of Mahatma Gandhi University of Medical Sciences and Technology · doi:10.5005/jp-journals-10057-0041
Rodriguez‐Dimitrescu, C. (2012) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3v913
ACSL4 gen polimorfizminin (rs7886473) metabolik sendrom ve lipid düzeyleri üzerine etkisi
Vurgun, E., Diker, I. Y., Çoban, N., Geyik, F. D., Guven, G. S., & Erginel‐Ünaltuna, N. (2018) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.407589
Effects of Resistance Exercise on Postprandial Metabolism in Obese Men with Prediabetes
Bittel, A. J. (2018) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/tdvz-6g03
The role of folate in non-alcoholic fatty liver disease
Sid, V. (2019) · Mspace (University of Manitoba)
Guo, H. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/24s6-mr73
Adipose Tissue-Liver Axis: a key Link in Adiposity
Rosero, R., Am, G., Palacio, J. I., Jaramillo, A. U., & Polanco, J. P. (2019) · Diabetes & its Complications · doi:10.33425/2639-9326.1042
Farr, S. (2017) · TSpace (University of Toronto)
Diabetes mellitus & disorders of lipid metabolism
Steinmetz, A. (2015) · doi:10.4155/fseb2013.14.200
Li, C., Kong, W., Kang, L., Zhang, T., Zhang, W., & Wang, W. (2020) · Journal of Medical Biochemistry · doi:10.5937/jomb0-24666
NAFLD and Cardiovascular and Cardiac Disease: Clinical Implications
Scorletti, E., & Byrne, C. D. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_9
Taher, J. (2017) · TSpace (University of Toronto)
Shenoy, K., Leena, K. B., & Sheela Shenoy, T. (2020) · Indian Journal Of Applied Research · doi:10.36106/ijar/6000585
Plasma lipoprotein profile from nonalcoholic steatohepatitis model rats
Toshima, G., Hiwatashi, K., Takahashi, J., OGIHARA, K., Naya, Y., Sasaki, A., & Hata, K. (2020) · Biomedical Research · doi:10.2220/biomedres.41.289
Nonalcoholic fatty liver disease in relation to cardiovascular disease
Simons, N. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20210226ns
Is the United States Claims Court Constitutional
Baker, J. E. (1983) · EngagedScholarship @ Cleveland State University (Cleveland State University)
Uzunova, A., Chaneva, C., Boicheva, S., & Veicheva, V. (2004) · Comptes Rendus De L Academie Bulgare Des Sciences
Current literature in diabetes
(2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.668
Exercise and training in NAFLD and insulin resistance
Brouwers, B. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160624bb
Désordres cliniques et biologiques associés
(2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75889-8.00005-1
Ren, Z., Simons, P. I. H. G., Wesselius, A., Stehouwer, C. D. A., & Brouwers, M. C. G. J. (2022) · Hepatology · doi:10.1002/hep.32611
de Souza, L. A. V., Burgos, M. G. P. D. A., Duarte, G. S., Borba, J. M. C., de Andrade, L. A. S. S., dos Santos, M. H. L. R., Maio, R., & dos Santos, T. M. M. (2022) · Brazilian Journal of Development · doi:10.34117/bjdv8n8-237
Improving flexibility in substrate metabolism
Veelen, A. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20230125av
Brouwers, M. C. G. J. (2022) · doi:10.26481/spe.20220218mb
Eriş, D. (2023) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.2576
karawia, Z., & Mansour, M. A. (2023) · Zagazig Veterinary Journal/Zagazig Veterinary Journal (Online) · doi:10.21608/zvjz.2023.192324.1207
Carbohydrate, Protein, and Fat Metabolism in Obesity
Galgani, J. E., Cortés, V., & Fernando Carrasco, N. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_21-2
Amirkalali, B., Hassanzadeh, P., Sheikholmolooki, F., Gholizadeh, E., Doustmohammadian, A., Tameshkel, F. S., Motamed, N., Maadi, M., Sohrabi, M., Sobhrakhshankhah, E., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1405833
Ren, Z., Wesselius, A., Kooi, M. E., van Greevenbroek, M. M. J., Dagnelie, P. C., Berendschot, T. T. J. M., Kroon, A. A., Houben, A. J. H. M., Stehouwer, C. D. A., & Brouwers, M. C. G. J. (2025) · Diabetologia · doi:10.1007/s00125-025-06479-3
Skeletal Muscle and Cardiovascular Health
Ruiz‐Ramie, J. J., Davis, P. G., Anderson, E., & Durstine, J. L. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-88361-3_26
Hirano, T., Takeda, Y., Sakuma, I., Hiramitsu, S., Okada, M., Ueda, S., & Sakurai, M. (2025) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.65870
Lyngbæk, M. P. P., Legaard, G. E., Bennetsen, S. L., Feineis, C. S., Rasmussen, V., Moegelberg, N., Brinkløv, C. F., Nielsen, A. B., Kofoed, K. S., Lauridsen, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14361947
Lyngbæk, M. P. P., Legaard, G. E., Bennetsen, S. L., Feineis, C. S., Rasmussen, V., Moegelberg, N., Brinkløv, C. F., Nielsen, A. B., Kofoed, K. S., Lauridsen, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14361935
Lyngbæk, M. P. P., Legaard, G. E., Bennetsen, S. L., Feineis, C. S., Rasmussen, V., Moegelberg, N., Brinkløv, C. F., Nielsen, A. B., Kofoed, K. S., Lauridsen, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14361932
Lyngbæk, M. P. P., Legaard, G. E., Bennetsen, S. L., Feineis, C. S., Rasmussen, V., Moegelberg, N., Brinkløv, C. F., Nielsen, A. B., Kofoed, K. S., Lauridsen, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14361944
Lyngbæk, M. P. P., Legaard, G. E., Bennetsen, S. L., Feineis, C. S., Rasmussen, V., Moegelberg, N., Brinkløv, C. F., Nielsen, A. B., Kofoed, K. S., Lauridsen, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14361929
Lyngbæk, M. P. P., Legaard, G. E., Bennetsen, S. L., Feineis, C. S., Rasmussen, V., Moegelberg, N., Brinkløv, C. F., Nielsen, A. B., Kofoed, K. S., Lauridsen, C. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14361941
Tsay, E., Kurmaeva, D., Nuriddinov, S., Tsoy, V., Abduxalimova, S., Bozorov, S. S., Khalimova, Z., Engelsen, S. B., Magkos, F., Akbarovna, D. D., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03039-2
Wang, Z., Wang, D., Liu, Y., Jian, Z., Wang, M., & Lin, H. (2026) · Poultry Science · doi:10.1016/j.psj.2026.106376
Hirooka, M., Miyake, T., Yano, R., Nakamura, Y., Okazaki, Y., Shimamoto, T., Yukimoto, A., Yamamoto, Y., Watanabe, T., Yoshida, O., et al. (2026) · Gastro Hep Advances · doi:10.1016/j.gastha.2026.100882
(Liver steatosis as a risk of coronary heart disease)
Poledne, R., Pajuelo, D., & Lesná, I. K. (2025) · Cor et Vasa · doi:10.33678/cor.2025.116
Abdou, H. A., & Omar, S. A. (2026) · ASIDE Gastroenterology · doi:10.71079/aside.gi.031826446
Fang, Y., de Mutsert, R., Gijbels, A., Deng, K., Lamb, H. J., Rosendaal, F. R., Mook‐Kanamori, D. O., van Dijk, K. W., Afman, L. A., & Li‐Gao, R. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03158-4
Rôle des sphingolipides hépatiques dans la physiopathologie du diabète de type 2
Lachkar, F. (2022) · theses.fr (ABES) · doi:10.70675/2f1ce169zade5z47ccz96caz55bf77edab09
Perspective Chapter: Women’s Body Image – Medical Implications Across the Lifespan
Roman, D., Popescu, S., & Sorescu, T. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1015480
Krarup, K. B., Krarup, H. B., Pedersen, I. S., Mørk, M., Kristensen, S. R., Handberg, A., Wimmer, R., & Nguyen, H. T. T. (2026) · Metabolomics · doi:10.1007/s11306-026-02502-9
Konings, L., Xu, W., de Jong, V., Alings, M., Tardif, J., LINCOFF, A. M., Schwartz, G. G., Grobbee, D. E., & Cabezas, M. C. (2026) · Diabetology · doi:10.3390/diabetology7090162
Lei, S., Tao, J., Chen, X., Li, X., & Zhong, S. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-03055-5
Remnant clearance capacity: a new framework for early type 2 diabetes pathogenesis
Nakajima, K., Murakami, M., & Tanaka, A. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121345
Pasarín, M. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metadata
- Authors
- Adiels, M., Taskinen, M.-R., Packard, C., Caslake, M. J., Soro-Paavonen, A., Westerbacka, J., Vehkavaara, S., Häkkinen, A., Olofsson, S.-O., Yki-Järvinen, H., & Borén, J.
- Affiliations
- University of Gothenburg (SE)
- University of Helsinki (FI)
- Glasgow Royal Infirmary (GB)
- Sahlgrenska University Hospital (SE)
- Corresponding author
- Borén, J.
- Venue
- Diabetologia
- Published
- 2006-02-04
- Volume
- 49
- Issue
- 4
- Pages
- 755-765
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2051999166
- Cited by
- 690
- References
- 53
- Citations by year
- 2026: 15 · 2025: 26 · 2024: 29 · 2023: 21 · 2022: 35 · 2021: 29 · 2020: 40 · 2019: 31 · 2018: 27 · 2017: 27 · 2016: 37 · 2015: 41 · 2014: 41 · 2013: 45 · 2012: 38
- FWCI
- 26.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Chalmers Research (Chalmers University of Technology) (submittedVersion)
- Funders
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- Göran Gustafssons Stiftelser
- Hjärt-Lungfonden
- Vetenskapsrådet
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hepatic fat content, adiponectin, apolipoprotein B, triglyceride kinetics, type 2 diabetes, insulin resistance, intra-abdominal fat, dyslipidemia
- MeSH terms
- Adipose Tissue, Adult, Aged, Apolipoproteins B, Diabetes Mellitus, Type 2, Fatty Liver, Humans, Lipoproteins, VLDL, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
